Detection of novel CD antigens on the surface of human mast cells and basophils

被引:67
作者
Ghannadan, M
Hauswirth, AW
Schernthaner, GH
Müller, MR
Klepetko, W
Schatzl, G
Sperr, WR
Bühring, HJ
Valent, P
机构
[1] Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Surg, A-1090 Vienna, Austria
[3] Univ Vienna, Dept Urol, A-1090 Vienna, Austria
[4] Univ Tubingen, Dept Internal Med 2, D-72074 Tubingen, Germany
关键词
basophils; mast cells; SIRP-alpha; E-NPP3;
D O I
10.1159/000057747
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background. Mast cells (MC) and basophils are effector cells of allergic reactions. Growth and function of these cells are regulated by a network of cytokines, other ligands, and respective cell surface membrane receptors. Methods: In the present study, we examined the expression of novel CD antigens on human lung MC, skin MC, blood basophils, the MC line HMC-1, and the basophil cell line KU-812. Expression of surface antigens was analyzed by monoclonal antibodies (mAbs) and indirect immunofluorescence staining techniques. Results: Primary MC were found to react with mAbs against KIT (CD117), the signal regulatory protein SIRP-alpha (CD172a), and the ectoenzynne E-NPP3 (CD203c). Human basophils were found to express large amounts of E-NPP3 and lower levels of Siglec-5 (CD170), CXCR4 (CD184) and SIRP-alpha. The HMC-1 cell line was recognized by mAbs against SIRP-alpha, CXCR4, endothelial protein C receptor (CD201) and E-NPP3. KU-812 cells were found to react with mAbs against E-NPP3, CXCR4 and glycophorin C (CD236R), but did not react with mAb against endothelial protein C receptor. Most of the other CD antigens tested disclosed negative results. Conclusions: In summary, our data provide further evidence that MC and basophils express a unique composition of surface antigens. The use of novel CD antibodies may help to isolate MC and basophils and to study their functional properties. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 45 条
  • [1] Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes
    Agis, H
    Fureder, W
    Bankl, HC
    Kundi, M
    Sperr, WR
    Willheim, M
    BoltzNitulescu, G
    Butterfield, JH
    Kishi, K
    Lechner, K
    Valent, P
    [J]. IMMUNOLOGY, 1996, 87 (04) : 535 - 543
  • [2] The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
    Bleul, CC
    Farzan, M
    Choe, H
    Parolin, C
    ClarkLewis, I
    Sodroski, J
    Springer, TA
    [J]. NATURE, 1996, 382 (6594) : 829 - 833
  • [3] FUNCTION AND EXPRESSION OF ADHESION MOLECULES ON HUMAN BASOPHILS
    BOCHNER, BS
    STERBINSKY, SA
    KNOL, EF
    KATZ, BJ
    LICHTENSTEIN, LM
    MACGLASHAN, DW
    SCHLEIMER, RP
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (06) : 1157 - 1162
  • [4] The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3
    Bühring, HJ
    Seiffert, M
    Giesert, C
    Marxer, A
    Kanz, L
    Valent, P
    Sano, K
    [J]. BLOOD, 2001, 97 (10) : 3303 - 3305
  • [5] Bühring HJ, 1999, BLOOD, V94, P2343
  • [6] BUHRING HJ, IN PRESS LEUCOCYTE T, V7
  • [7] ESTABLISHMENT OF AN IMMATURE MAST-CELL LINE FROM A PATIENT WITH MAST-CELL LEUKEMIA
    BUTTERFIELD, JH
    WEILER, D
    DEWALD, G
    GLEICH, GJ
    [J]. LEUKEMIA RESEARCH, 1988, 12 (04) : 345 - 355
  • [8] Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33
    Cornish, AL
    Freeman, S
    Forbes, G
    Ni, J
    Zhang, M
    Cepeda, M
    Gentz, R
    Augustus, M
    Carter, KC
    Crocker, PR
    [J]. BLOOD, 1998, 92 (06) : 2123 - 2132
  • [9] FUREDER W, 1995, J IMMUNOL, V155, P3152
  • [10] Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies
    Ghannadan, M
    Baghestanian, M
    Wimazal, F
    Eisenmenger, M
    Latal, D
    Kargül, G
    Walchshofer, S
    Sillaber, C
    Lechner, K
    Valent, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (04) : 689 - 695